Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Sprout Health vs HealthRX

Sprout Health
Graded #12

Level

vs
HealthRX
Graded #10

Level

The verdict

Too close to call — both grade 86/100 (B).

Sprout Health and HealthRX land on the same WeighScore, so neither clears the other on our six graded dimensions. HealthRX sits one line higher on the board (#10 vs #12) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.

Assume any provider we list may compensate us — we may earn a commission at no cost to you. It never changes the WeighScore.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSprout Health +5
90
85
Dose & formulationHealthRX +8
82
90
Clinical oversightSprout Health +1
88
87
Labs & monitoringSprout Health +10
92
82
FulfillmentHealthRX +8
78
86
Contract termsHealthRX +1
84
85
Sprout Health · left barHealthRX · right bar

The numbers

MetricSprout HealthHealthRX
WeighScore86/10086/100
GradeBB
Scorecard rank#12#10
Semaglutide$149/mo$189/mo
Tirzepatide$199/mo$349/mo
CoverageNot disclosedNot publicly listed
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
Sprout Health

Graded #12 · B

Strengths

  • LegitScript-certified with a listed address and contact line
  • Both compounded ($149 semaglutide / $199 tirzepatide) and a genuine brand-name Wegovy/Zepbound route
  • Low-friction intake — no labs and often no telehealth visit required

Where it loses points

  • Compounded semaglutide and tirzepatide are not FDA-approved
  • No oral or sublingual route — injectable only
  • Thin transparency — no named medical director, and state availability is quiz-gated
  • "No labs, no visit" convenience also means lighter clinical oversight
HealthRX

Graded #10 · B

Strengths

  • LegitScript-certified (#50087439) — a genuine, verifiable trust signal
  • Physician-supervised intake with licensed providers
  • Both molecules plus a rare oral GLP tablet option
  • Transparent flat monthly pricing, no insurance required

Where it loses points

  • Compounded semaglutide/tirzepatide is not FDA-approved
  • Some tiers are company-stated and the public site is thin
  • Brand Ozempic is a steep pass-through (~$1,299)
  • State count is not publicly listed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 37 providers, CoreAge Rx grades highest at 94/100 (A). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard